Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments


Ontology type: sgo:Patent     


Patent Info

DATE

2011-10-11T00:00

AUTHORS

LUSTENBERGER PHILIPP , KONETZKI INGO , SIEGER PETER

ABSTRACT

Enantiomerically pure compounds of general formula 1 wherein the groups R1, R2, R3, R4, and X− may have the meanings given in the claims and in the specification, processes for preparing them and the use thereof as pharmaceutical compositions, particularly as pharmaceutical compositions for the treatment of respiratory complaints.

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/48", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/4806", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "name": "LUSTENBERGER PHILIPP", 
        "type": "Person"
      }, 
      {
        "name": "KONETZKI INGO", 
        "type": "Person"
      }, 
      {
        "name": "SIEGER PETER", 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.2165/00002018-200427040-00003", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008046870", 
          "https://doi.org/10.2165/00002018-200427040-00003"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.2165/00002018-200427100-00001", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048743769", 
          "https://doi.org/10.2165/00002018-200427100-00001"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2011-10-11T00:00", 
    "description": "

Enantiomerically pure compounds of general formula 1

\n

\"embedded
\nwherein the groups R1, R2, R3, R4, and X may have the meanings given in the claims and in the specification, processes for preparing them and the use thereof as pharmaceutical compositions, particularly as pharmaceutical compositions for the treatment of respiratory complaints.\n

", "endDate": "2025-09-12", "id": "sg:patent.US-8034809-B2", "name": "Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments", "recipient": [ { "id": "http://www.grid.ac/institutes/grid.420061.1", "type": "Organization" } ], "sameAs": [ "https://app.dimensions.ai/details/patent/US-8034809-B2" ], "sdDataset": "patents", "sdDatePublished": "2022-12-01T06:59", "sdLicense": "https://scigraph.springernature.com/explorer/license/", "sdPublisher": { "name": "Springer Nature - SN SciGraph project", "type": "Organization" }, "sdSource": "s3://com-springernature-scigraph/baseset/20221201/entities/gbq_results/patent/patent_8.jsonl", "type": "Patent" } ]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/patent.US-8034809-B2'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/patent.US-8034809-B2'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/patent.US-8034809-B2'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/patent.US-8034809-B2'


 

This table displays all metadata directly associated to this object as RDF triples.

42 TRIPLES      15 PREDICATES      18 URIs      9 LITERALS      2 BLANK NODES

Subject Predicate Object
1 sg:patent.US-8034809-B2 schema:about anzsrc-for:48
2 anzsrc-for:4806
3 schema:author N3859f216c6354a22a9f4ce9cff273e68
4 schema:citation sg:pub.10.2165/00002018-200427040-00003
5 sg:pub.10.2165/00002018-200427100-00001
6 schema:datePublished 2011-10-11T00:00
7 schema:description <p num="p-0001">Enantiomerically pure compounds of general formula 1</p> <p num="p-0002"><chemistry id="CHEM-US-00001" num="00001"><img id="EMI-C00001" he="39.20mm" wi="76.12mm" file="US08034809-20111011-C00001.TIF" alt="embedded image" img-content="chem" img-format="tif" orientation="portrait" inline="no"/><attachments><attachment idref="CHEM-US-00001" attachment-type="cdx" file="US08034809-20111011-C00001.CDX"/><attachment idref="CHEM-US-00001" attachment-type="mol" file="US08034809-20111011-C00001.MOL"/></attachments></chemistry><br/> wherein the groups R<sup>1</sup>, R<sup>2</sup>, R<sup>3</sup>, R<sup>4</sup>, and X<sup>&#8722;</sup> may have the meanings given in the claims and in the specification, processes for preparing them and the use thereof as pharmaceutical compositions, particularly as pharmaceutical compositions for the treatment of respiratory complaints. </p>
8 schema:endDate 2025-09-12
9 schema:name Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments
10 schema:recipient grid-institutes:grid.420061.1
11 schema:sameAs https://app.dimensions.ai/details/patent/US-8034809-B2
12 schema:sdDatePublished 2022-12-01T06:59
13 schema:sdLicense https://scigraph.springernature.com/explorer/license/
14 schema:sdPublisher Naeb24be5e2914f0293bde70e478cf35e
15 sgo:license sg:explorer/license/
16 sgo:sdDataset patents
17 rdf:type sgo:Patent
18 N2011437fe7fd42549f322e912d3db43b schema:name KONETZKI INGO
19 rdf:type schema:Person
20 N20ed1791f7bd4d41b38dcfc4b0d632bf rdf:first N2011437fe7fd42549f322e912d3db43b
21 rdf:rest N35f3c9de35a44de1858b759374c28d71
22 N35f3c9de35a44de1858b759374c28d71 rdf:first N814ab1e67fff466c8d99afdf2f591415
23 rdf:rest rdf:nil
24 N3859f216c6354a22a9f4ce9cff273e68 rdf:first N3cdafba9db59452d8a1905c991fa34bc
25 rdf:rest N20ed1791f7bd4d41b38dcfc4b0d632bf
26 N3cdafba9db59452d8a1905c991fa34bc schema:name LUSTENBERGER PHILIPP
27 rdf:type schema:Person
28 N814ab1e67fff466c8d99afdf2f591415 schema:name SIEGER PETER
29 rdf:type schema:Person
30 Naeb24be5e2914f0293bde70e478cf35e schema:name Springer Nature - SN SciGraph project
31 rdf:type schema:Organization
32 anzsrc-for:48 schema:inDefinedTermSet anzsrc-for:
33 rdf:type schema:DefinedTerm
34 anzsrc-for:4806 schema:inDefinedTermSet anzsrc-for:
35 rdf:type schema:DefinedTerm
36 sg:pub.10.2165/00002018-200427040-00003 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008046870
37 https://doi.org/10.2165/00002018-200427040-00003
38 rdf:type schema:CreativeWork
39 sg:pub.10.2165/00002018-200427100-00001 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048743769
40 https://doi.org/10.2165/00002018-200427100-00001
41 rdf:type schema:CreativeWork
42 grid-institutes:grid.420061.1 schema:Organization
 




Preview window. Press ESC to close (or click here)


...